美股異動|蘋果盤前跌近3% 公司估計關稅將增加9億美元成本
蘋果(AAPL.US)盤前跌2.81%,報207.33美元。蘋果第二財季EPS爲1.65美元,略高於分析師預期的1.62美元;營收953.6億美元,分析師預期945.9億美元;大中華區營收160.0億美元,分析師預期168.3億美元。蘋果公司董事會授權回購不超過1000億美元股票,並提高派息。蘋果CEO庫克在財報電話會議上表示,由於公司轉移了供應鏈和庫存,蘋果公司認爲關稅對第二財季的影響“有限”。“但對於截至6月的季度(第三財季),假設當前的全球關稅稅率、政策和實施在本季度剩餘時間內沒有變化,也沒有新增的關稅,估計其影響將使我們的成本增加9億美元。”(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.